| Lincoln Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531633 |
NSE Symbol : LINCOLN |
P/E(TTM) : 16.82 |
|
ISIN Demat : INE405C01035 |
Div & Yield% : 0.22 |
EPS(TTM) : 48.25 |
|
Book Value(₹) : 319.16 |
Market Cap(₹Cr) : 1,625.81 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 161.21 | 147.28 | 142.49 | 146.45 | 155.99 | 135.62 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 161.21 | 147.28 | 142.49 | 146.45 | 155.99 | 135.62 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 9.98 | 10.41 | 7.02 | 11.02 | 8.69 | 7.69 |
| Total Income | 171.19 | 157.69 | 149.51 | 157.47 | 164.68 | 143.31 |
| Total Expenditure | 132.83 | 124.55 | 124.11 | 116.79 | 124.84 | 114.90 |
| PBIDT | 38.36 | 33.14 | 25.40 | 40.68 | 39.84 | 28.41 |
| Interest | 0.35 | 0.44 | 0.50 | 0.15 | 0.39 | 0.41 |
| PBDT | 38.01 | 32.70 | 24.90 | 40.52 | 39.45 | 27.99 |
| Depreciation | 3.22 | 3.22 | 2.69 | 2.81 | 2.58 | 2.55 |
| Tax | 5.12 | 5.51 | 4.11 | 7.21 | 8.61 | 5.51 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.33 | 0.29 | -0.49 | 2.46 | 0.60 | 0.92 |
| Reported Profit After Tax | 26.33 | 23.67 | 18.60 | 28.04 | 27.65 | 19.01 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 26.33 | 23.67 | 18.60 | 28.04 | 27.65 | 19.01 |
| EPS (Unit Curr.) | 13.15 | 11.82 | 9.28 | 14.00 | 13.81 | 9.49 |
| EPS (Adj) (Unit Curr.) | 13.15 | 11.82 | 9.28 | 14.00 | 13.81 | 9.49 |
| Calculated EPS (Unit Curr.) | 13.15 | 11.82 | 9.28 | 14.00 | 13.81 | 9.49 |
| Calculated EPS (Adj) (Unit Curr.) | 13.15 | 11.82 | 9.28 | 14.00 | 13.81 | 9.49 |
| Calculated EPS (Ann.) (Unit Curr.) | 52.58 | 47.27 | 37.14 | 56.00 | 55.23 | 37.97 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 52.58 | 47.27 | 37.14 | 56.00 | 55.23 | 37.97 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 20.03 | 20.03 | 20.03 | 20.03 | 20.03 | 20.03 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 23.80 | 22.50 | 17.83 | 27.78 | 25.54 | 20.95 |
| PBDTM(%) | 23.58 | 22.20 | 17.47 | 27.67 | 25.29 | 20.64 |
| PATM(%) | 16.33 | 16.07 | 13.05 | 19.15 | 17.73 | 14.02 |